Laetitia Bral-Nebot
Villejuif, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Glucocorticoids unleash immune-dependent melanoma control through inhibition of the GARP/TGF-β axis.
Glucocorticoids unleash immune-dependent melanoma control through inhibition of the GARP/TGF-β axis.
Journal: bioRxiv : the preprint server for biology
Published: August 06, 2025
Effect of MisMatch repair deficiency on metastasis occurrence in a syngeneic mouse model.
Journal: Neoplasia (New York, N.Y.)
Published: December 20, 2024
Glucocorticoids Unleash Immune-dependent Melanoma Control through Inhibition of the GARP/TGFβ Axis.
Journal: Cancer discovery
Published: August 25, 2024
Overcoming resistance to αPD-1 of MMR-deficient tumors with high tumor-induced neutrophils levels by combination of αCTLA-4 and αPD-1 blockers.
Journal: Journal for immunotherapy of cancer
Published: June 30, 2022
Predicting immunotherapy outcomes in patients with MSI tumors using NLR and CT global tumor volume.
Journal: Frontiers in oncology
Published: June 30, 2022
Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer.
Journal: Nature communications
Published: April 04, 2019
Why is immunotherapy effective (or not) in patients with MSI/MMRD tumors?
Journal: Bulletin du cancer
Published: July 19, 2018
Hypermutated tumours in the era of immunotherapy: The paradigm of personalised medicine.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 14, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026